Company intelligence / Profile preview
C-Biomex Co., Ltd.
Pohang, Gyeongsangbuk-do, South Koreacbiomex.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
C-Biomex has developed robust preclinical data supporting its peptide radiopharmaceutical approach using the proprietary CUS™ platform. The company claims heightened serum stability and binding affinity with their peptides, aiming at improved safety and efficacy in targeted cancer theranostics. No published clinical results as of May 2025.
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Peptide-based radiopharmaceuticals (radioligand therapies)Peptides for diagnostic and therapeutic use (theranostics)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Past strategic partnerships led by key personnel at previous companies are mentioned, but no current major pharma/biotech partnerships specifically named for C-Biomex itself.
Beyond the preview
Go deeper on C-Biomex Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C-Biomex Co., Ltd..